Lung Cancer Treatment Market | Size, Key Developments & Growth Opportunities

Market Size and Growth

The global lung cancer treatment market size reached US$ 32.64 billion in 2024 and is expected to reach US$ 73.29 billion by 2033, growing at a CAGR of 9.5% during the forecast period 2025-2033.

DataM Intelligence has released its latest research, "Lung Cancer Treatment Market Size 2025," providing a detailed overview of the industry. The report offers a deep dive into key market drivers, regional growth, and the competitive landscape, equipping businesses with the insights needed to navigate this dynamic sector.

Mergers and acquisition

BMS-BioNTech collaboration on BNT327:

$1.5 bn upfront; up to $9.6 bn total including milestones and anniversary payments.

Targets PD-L1/VEGF-A bispecific antibody in Phase III trials for SCLC and NSCLC.

Bayer partnership with Kumquat Biosciences:

Up to $1.3 bn for development of KRAS G12D inhibitor, addressing lung, pancreatic, and colorectal cancers.

Lantheus Holdings expands radiopharma capabilities:

Acquired Evergreen Theragnostics (~$1 bn total) and planning a $350 m acquisition of LMI for oncology diagnostics and imaging.

Download an Exclusive Sample PDF (Use Corporate email ID to Get Higher Priority) at: https://www.datamintelligence.com/download-sample/lung-cancer-treatment-market?sb

Lung cancer treatment involves medical approaches such as surgery, chemotherapy, radiation, targeted therapy, and immunotherapy to remove or control cancer cells in the lungs. It aims to improve survival, reduce symptoms, and enhance the patient's quality of life.

Key players:

The section also contains information related to the new product launches, mergers, acquisitions, collaborations, etc., to give a clear understanding about the competitive landscape prevailing in the global market. With an emphasis on strategies there have been several primary developments done by major companies such as :

-> Merck & Co., Inc., Pfizer Inc., AstraZeneca, Amgen Inc., Eli Lilly and Company, Bristol-Myers Squibb Company, Takeda Pharmaceuticals U.S.A., Inc., Amneal Pharmaceuticals LLC., Genentech USA, Inc., Rigel Pharmaceuticals, Inc., Daiichi Sankyo, Inc. and among others.

Key Developments:

✔ In August 2025, Verastem Oncology announced updated Phase 1/2 data for GFH375, an oral KRAS G12D inhibitor in NSCLC, showing a 68.8% overall response rate at the recommended Phase 2 dose.

✔ In August 2025, the U.S. FDA approved Hernexeos, a kinase inhibitor for previously treated non-squamous NSCLC with a specific genetic mutation about 75% of patients experienced tumor disappearance or major reduction. A companion diagnostic was also cleared.

✔ In August 2025, Bayer struck a global licensing deal with Kumquat Biosciences to develop a KRAS G12D inhibitor, aiming to bring this promising targeted therapy relevant for NSCLC through clinical trials toward commercialization.

Market Segments:

By Cancer Type: Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), Lung Carcinoid Tumors, Others

By Treatment Type: Chemotherapy, Radiation Therapy, Targeted Therapy, Surgery, Others

Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/lung-cancer-treatment-market?sb

Research Process

Both primary and secondary data sources have been used in the global Lung Cancer Treatment Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Regional Analysis for Lung Cancer Treatment Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

**The full version of the report includes an in-depth analysis of emerging players and startups, which will provide valuable insights into the evolving market landscape and key strategies being adopted**

This Report Covers:

✔ Go-to-market Strategy.

✔ Neutral perspective on the market performance.

✔Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, and other significant analysis, as well as development status.

✔Customized regional/country reports as per request and country level analysis.

✔ Potential & niche segments and regions exhibiting promising growth covered.

✔ Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer).

Looking For Full Report? Get it here: https://www.datamintelligence.com/buy-now-page?report=lung-cancer-treatment-market

Chapter Outline

⏩ Market Overview: The report analyzes key drivers, challenges, and opportunities shaping the industry, providing a clear picture of the forces at play.

⏩ Market Landscape: A thorough evaluation of leading industry players, including their financial performance, key product offerings, and strategic initiatives

⏩ Companies Profiles: The global Lung Cancer Treatment market's leading players are studied based on sales, main products, gross profit margin, revenue, price, and growth production.

⏩ Market Outlook by Region: A detailed breakdown of market trends, size, and growth projections across major regions, including North America, Europe, Asia Pacific, the Middle East & Africa, and South America.

⏩ Market Segments: An interpretation of how various segments by end-user, application, and type contribute to the market's overall value and growth..

⏩ Market Forecast: Production Side: Expert analysis on the production and value forecasts for the market, offering a glimpse into its trajectory.

⏩ Research Findings: This section of the report showcases the findings and analysis of the report.

⏩ Conclusion: This portion of the report is the last section of the report where the conclusion of the research study is provided.

Frequently asked questions:

What is the current valuation of the Lung Cancer Treatment Market?

A: In 2024, the global Lung Cancer Treatment Market was valued at a US$ 32.64 billion reflecting its substantial role in the sector.

Q: What is the projected size of the Lung Cancer Treatment Market by 2033?

A: Experts forecast a significant expansion, with the Lung Cancer Treatment Market anticipated to reach a valuation of nearly US$ 73.29 billion by 2033, driven by ongoing demand and projects.

Q: What is the expected growth rate for the Lung Cancer Treatment Market?

A: The market is poised for steady growth, with a projected Compound Annual Growth Rate (CAGR) of around 9.5% during the forecast period. This growth is fueled by increasing global needs and investments

Request for 2 Days FREE Trial Access: https://www.datamintelligence.com/reports-subscription?sb

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg?sb

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.